Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches.
Fast-Acting Novel Depression Tx; Lumryz Label Expanded; GLP-1s for Addiction?
As an adjunctive treatment to antidepressants, investigational SPN-820 — a novel, first-in-class intracellular modulator of mTORC1 that was developed to provide a rapid-onset response —
October 24, 2024